Moving forward: may some of “functional” gut disorders be reclassified as enteric neuro-gliopathies?

Gabrio Bassotti

Exploration of Neuroscience ›› 2025, Vol. 4 ›› Issue (1) : 100683

PDF (1341KB)
Exploration of Neuroscience ›› 2025, Vol. 4 ›› Issue (1) :100683 DOI: 10.37349/en.2025.100683
research-article
Moving forward: may some of “functional” gut disorders be reclassified as enteric neuro-gliopathies?
Author information +
History +
PDF (1341KB)

Abstract

“Functional” gut disorders are clinical conditions frequently encountered in clinical practice, often characterized by abnormalities of the intestinal sensory and motor functions. Although traditionally believed not harboring organic abnormalities, some of these disorders have been demonstrated to have more or less subtle involvement of the enteric nervous system. This involvement has been especially documented for enteric glial cells, even though other elements may be involved. Given the pivotal role of enteric glial cells in gut pathophysiology and their evident abnormalities in some disorders of gut-brain interaction, it may be time to reconsider their role and recognize them as an important pathophysiological factor in these conditions. Thus, due to the prominent neuronal and glial involvement in some clinically severe forms, it is proposed that at least some of the “functional” gut disorders should be reclassified as enteric neuro-gliopathies.

Keywords

Enteric gliopathies / enteric neuropathies / functional gut disorders

Cite this article

Download citation ▾
Gabrio Bassotti. Moving forward: may some of “functional” gut disorders be reclassified as enteric neuro-gliopathies?. Exploration of Neuroscience, 2025, 4 (1) : 100683 DOI:10.37349/en.2025.100683

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Tome J,Kamboj AK,Loftus CG.Approach to Disorders of Gut-Brain Interaction.Mayo Clin Proc.2023;98:458-67.

[2]

Neri L,Basilisco G,Corazziari E,Stanghellini V,Bassotti G,Bellini M,et al.LIRS Study Group.Constipation severity is associated with productivity losses and healthcare utilization in patients with chronic constipation.United European Gastroenterol J.2014;2:138-47.

[3]

Neri L,Iovino PLaxative Inadequate Relief Survey (LIRS) Group.Bloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation-predominant irritable bowel syndrome and functional constipation.Neurogastroenterol Motil.2016;28:581-91.

[4]

Thompson WG,Longstreth GF,Drossman DA,Heaton KW,Irvine EJ,Müller-Lissner SA.Functional bowel disorders and functional abdominal pain.Gut.1999;45:II43-7.

[5]

Schmulson MJ,Drossman DA.What Is New in Rome IV.J Neurogastroenterol Motil.2017;23:151-63.

[6]

Bassotti G,Villanacci V,Fisogni S,Rossi E,Baronio P,Clerici C,et al.Enteric glial cells and their role in gastrointestinal motor abnormalities: introducing the neuro-gliopathies.World J Gastroenterol.2007;13:4035-41.

[7]

Drossman DA,Hasler WL.Rome IV—Functional GI Disorders: Disorders of Gut-Brain Interaction.Gastroenterology.2016;150:1257-61.

[8]

El-Salhy M,Gundersen D,Gilja OH,Hatlebakk JG,Hausken T.Is irritable bowel syndrome an organic disorder?World J Gastroenterol.2014;20:384-400.

[9]

Wouters MM,Vicario M,Santos J.The role of mast cells in functional GI disorders.Gut.2016;65:155-68.

[10]

Yuan Y,Wang X,Huang S,Wang H,Shen G.Low-level inflammation, immunity, and brain-gut axis in IBS: unraveling the complex relationships.Gut Microbes.2023;15:2263209.

[11]

Santhosh S,Zanoletti L,Stamp LA,Hao MM,Matteoli G.From diversity to disease: unravelling the role of enteric glial cells.Front Immunol.2024;15:1408744.

[12]

Bernardini N,Ippolito C,Segnani C,Mattii L,Bassotti G,Villanacci V,et al.Histopathology in gastrointestinal neuromuscular diseases: methodological and ontological issues.Adv Anat Pathol.2013;20:17-31.

[13]

Thomasi B,Gulbransen B.Mini-review: Intercellular communication between enteric glia and neurons.Neurosci Lett.2023;806:137263.

[14]

Bassotti G,Villanacci V,Antonelli E,Morelli A,Salerni B.Enteric glial cells: new players in gastrointestinal motility?Lab Invest.2007;87:628-32.

[15]

Sanders KM,Santana LF,Baker SA.Interstitial cells of Cajal – pacemakers of the gastrointestinal tract.J Physiol.2025;[Epub ahead of print]

[16]

Törnblom H,Lindberg G,Nyberg B,Veress B.Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome.Gastroenterology.2002;123:1972-9.

[17]

Linan-Rico A,Ochoa-Cortes F,Schneider R,Christofi FL.Mini-review: Enteric glial cell reactions to inflammation and potential therapeutic implications for GI diseases, motility disorders, and abdominal pain.Neurosci Lett.2023;812:137395.

[18]

Pastras P,Aggeletopoulou I,Triantos C.Impact of Enteric Nervous Cells on Irritable Bowel Syndrome: Potential Treatment Options.Microorganisms.2024;12:2036.

[19]

Lilli NL,Quénéhervé L,Haddara S,Brochard C,Aubert P,Rolli-Derkinderen M,et al.Glioplasticity in irritable bowel syndrome.Neurogastroenterol Motil.2018;30:e13232.

[20]

Bassotti G,Chistolini F,Nzepa FS,Morelli A.Colonic propulsive impairment in intractable slow-transit constipation.Arch Surg.2003;138:1302-4.

[21]

Bassotti G,Satta PU,Bellini M.Chronic Idiopathic Constipation in Adults: A Review on Current Guidelines and Emerging Treatment Options.Clin Exp Gastroenterol.2021;14:413-28.

[22]

Bassotti G,Villanacci V,Maurer CA,Fisogni S,Fabio FD,Cadei M,et al.The role of glial cells and apoptosis of enteric neurones in the neuropathology of intractable slow transit constipation.Gut.2006;55:41-6.

[23]

Bassotti G,Villanacci V,Cathomas G,Maurer CA,Fisogni S,Cadei M,et al.Enteric neuropathology of the terminal ileum in patients with intractable slow-transit constipation.Hum Pathol.2006;37:1252-8.

[24]

Bassotti G,Stanghellini V,Chiarioni G,Germani U,Giorgio RD,Vantini I,et al.Upper gastrointestinal motor activity in patients with slow-transit constipation. Further evidence for an enteric neuropathy.Dig Dis Sci.1996;41:1999-2005.

[25]

Bassotti G,Villanacci V,Nascimbeni R,Asteria CR,Fisogni S,Nesi G,et al.Colonic neuropathological aspects in patients with intractable constipation due to obstructed defecation.Mod Pathol.2007;20:367-74.

[26]

Bassotti G,Villanacci V,Nascimbeni R,Cadei M,Manenti S,Antonelli E,et al.Increase of colonic mast cells in obstructed defecation and their relationship with enteric glia.Dig Dis Sci.2012;57:65-71.

[27]

Iantorno G,Bassotti G,Kogan Z,Lumi CM,Cabanne AM,Fisogni S,et al.The enteric nervous system in chagasic and idiopathic megacolon.Am J Surg Pathol.2007;31:460-8.

[28]

Giorgio RD,Stanghellini V,Barbara G,Corinaldesi R,Ponti FD,Tonini M,et al.Primary enteric neuropathies underlying gastrointestinal motor dysfunction.Scand J Gastroenterol.2000;35:114-22.

[29]

Selgrad M,Giorgio RD,Fini L,Cogliandro RF,Williams S,Stanghellini V,et al.JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction.Gut.2009;58:25-32.

[30]

Ahmadzai MM,McClain JL,Dharshika C,Seguella L,Giancola F,Giorgio RD,et al.LPAR1 regulates enteric nervous system function through glial signaling and contributes to chronic intestinal pseudo-obstruction.J Clin Invest.2022;132:e149464.

[31]

Burns AJ,Goldstein AM,Newgreen DF,Stamp L,Schäfer K,Metzger M,et al.White paper on guidelines concerning enteric nervous system stem cell therapy for enteric neuropathies.Dev Biol.2016;417:229-51.

[32]

Drokhlyansky E,Smillie CS,Van Wittenberghe N,Ericsson M,Griffin GK,Eraslan G,et al.The Human and Mouse Enteric Nervous System at Single-Cell Resolution.Cell.2020;182:1606-22.e23.

[33]

Obata Y,Castaño Á,Fallesen TL,Bon-Frauches AC,Boeing S,Huseynova A,et al.Molecular profiling of enteric nervous system cell lineages.Nat Protoc.2022;17:1789-817.

[34]

Villanacci V,Annese V,Cuttitta A,Fisogni S,Scaramuzzi G,Santo ED,et al.An immunohistochemical study of the myenteric plexus in idiopathic achalasia.J Clin Gastroenterol.2010;44:407-10.

PDF (1341KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/